Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Virpax Pharmaceuticals, Inc. (VRPX)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Dec-31-22Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21
   10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q
OPERATING EXPENSES          
General and administrative  9.09.711.111.78.47.77.2 
Research and development  5.67.69.711.210.07.14.8 
    Total operating expenses  31.036.343.355.546.639.534.2 
    Loss from operations  -15.7-18.4-21.8-22.9-18.4-14.8-12.0 
   
OTHER INCOME          
Other income  0.40.30.20.10.0 -0.1 
    Loss before tax provision  -15.3-18.0-21.7-22.8-18.4-14.8-12.1 
   
Income taxes          
    Net loss  -15.3-18.0-21.7-22.8-18.4-14.8-12.1 
   
Basic and diluted net loss per share (in Dollars per share)  ($1.31)($1.54)($1.85)($1.81)($1.69)($1.66)($1.82) 
   
Basic and diluted weighted average common stock outstanding (in Shares)  11.711.711.710.59.07.35.4 

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy